The Role of Left Ventricular Outflow Tract (LVOT) Velocity-time Integral (VTI) and Respiratory Variability at Peak Rate (Vpeak) in Predicting Hypotension After General Anesthesia Induction
LVOT-VTI-hypot
1 other identifier
observational
100
0 countries
N/A
Brief Summary
Preoperatively, patients will undergo transthoracic echocardiography measurements approximately 15-30 minutes before induction. TTE will be performed on all patients by an experienced observer; the echocardiography device will be equipped with an S4-2 transducer (4-2 MHz frequency range) in the left lateral decubitus position. VTI and Vpeak values of the LVOT were measured from manually drawn contours using pulsatile wave Doppler technique in the apical five-chamber view. The Doppler beam was aligned with the aortic blood flow, and the signal was captured at an appropriate angle (\<20°). The maximum (VTImax) and minimum (VTImin) VTI, as well as the maximum (Vpeakmax) and minimum (Vpeakmin) Vpeak values, were determined over three respiratory cycles. ΔVTI was calculated with the following formula: ΔVTI = \[2 × (VTImax - VTImin) / (VTImax + VTImin)\] × 100%. ΔVpeak was calculated with the following formula: ΔVpeak = \[2 × (Vpeakmax - Vpeakmin) / (Vpeakmax + Vpeakmin)\] × 100%. These parameters were analyzed to evaluate the hemodynamic status of patients and estimate fluid responsiveness. Patients with a 30% decrease from baseline in SBP and a decrease in MAP below 60 mmHg in the first 10 minutes after anesthesia induction were considered to have hypotension. Patients were divided into two groups: "with" and "without" hypotension.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Aug 2025
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 7, 2025
CompletedFirst Posted
Study publicly available on registry
August 13, 2025
CompletedStudy Start
First participant enrolled
August 20, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 20, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2025
CompletedAugust 13, 2025
August 1, 2025
Same day
August 7, 2025
August 7, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
lvot-vtı
The relationship between hypotension following induction of general anesthesia and respiratory variability in left ventricular outflow tract VTI peak velocity (Vpeak variability).
1 hour
Secondary Outcomes (1)
lv echo
1 hour
Study Arms (2)
with hypotension
Patients with a 30% decrease in SBP from baseline and a decrease in MAP below 65 mmHg in the first 10 minutes after anesthesia induction will be considered to have hypotension.
none hypotension
Patients with a 30% decrease in SBP from baseline and a decrease in MAP below 65 mmHg in the first 10 minutes after anesthesia induction will be considered to have hypotension.
Interventions
Hypotensive attacks with MAP below 55 mmHg or prolonged duration (2 minutes or more) will be treated with ephedrine 0.1 mg/kg.
Eligibility Criteria
This study will be conducted on hemodynamically stable patients aged between 18 and 75 years, with an American Society of Anesthesiologists (ASA) physical status classification of I-III, who are scheduled for elective surgery and will undergo general anesthesia.
You may qualify if:
- years
- ASA Physical Status 1-3;
- Patients scheduled for general anesthesia
You may not qualify if:
- Patient is pregnant
- Post-cardiac surgery
- Severe pulmonary hypertension
- Severe valvular disease
- Hypertrophic or dilated cardiomyopathy
- Presence of acute myocardial infarction
- Patients with severe visual or hearing impairment/impairment
- ASA physical status IV or V
- Ischemic heart disease, conduction disturbance
- History of long-term use of certain medications (β-blockers, angiotensin-converting enzyme inhibitors, analgesics, sedatives, or tricyclic antidepressants)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- PROSPECTIVE
- Target Duration
- 1 Day
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- asst. prof.dr
Study Record Dates
First Submitted
August 7, 2025
First Posted
August 13, 2025
Study Start
August 20, 2025
Primary Completion
August 20, 2025
Study Completion
September 1, 2025
Last Updated
August 13, 2025
Record last verified: 2025-08